Boullosa et al. [22] examined the expression of 12 tumour antigens (BCP-20, END, G250, HAGE, NY-ESO-1, PASD1, P68 RNA helicase, SSX2, SSX2IP, survivin, tyrosinase and WT1) in 11 adult B-ALL patient samples. This evidence concerns the gene BIRC5 and precursor B-cell acute lymphoblastic leukemia.